Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)
Ref: CC-RPH323Hu02-200
MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors
Información del producto
Información adicional
Size
200ug
Applications
Positive Control
Molecular Weight
40kDa
Research Area
Tumor immunity
Tags
N-terminal His and GST Tag
Minimum Purity
> 90%
Organism species
Homo sapiens (Human)
Alternative Names
MAPE
Item Name
Preferentially Expressed Antigen In Melanoma
Subcellular Location
Membrane, Nucleus
Isoelectric Point
6.2
Host
E.coli
Expression System
Prokaryotic expression
Traits
Freeze-dried powder
UniProt ID
P78395
Buffer Formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Tissue Source
Prokaryotic expression